| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 759.71B | 738.02B | 718.37B | 737.32B | 747.22B |
| Gross Profit | 196.81B | 204.32B | 198.75B | 207.88B | 211.09B |
| EBITDA | 40.40B | 29.48B | 30.07B | 46.66B | 56.58B |
| Net Income | 14.32B | 9.53B | 7.38B | 21.12B | 28.55B |
Balance Sheet | |||||
| Total Assets | 422.48B | 422.68B | 438.20B | 455.17B | 443.58B |
| Cash, Cash Equivalents and Short-Term Investments | 19.16B | 15.83B | 16.30B | 10.69B | 29.94B |
| Total Debt | 60.45B | 66.91B | 66.52B | 74.31B | 52.51B |
| Total Liabilities | 173.60B | 171.42B | 169.04B | 174.91B | 166.95B |
| Stockholders Equity | 248.88B | 251.26B | 269.16B | 280.25B | 276.63B |
Cash Flow | |||||
| Free Cash Flow | 28.32B | 25.33B | 31.37B | -21.59B | 15.15B |
| Operating Cash Flow | 37.52B | 36.17B | 48.83B | -2.18B | 24.23B |
| Investing Cash Flow | -11.17B | -15.80B | -16.48B | -18.45B | -9.57B |
| Financing Cash Flow | -24.83B | -27.33B | -26.75B | 1.38B | -12.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥382.39B | 8.06 | ― | 1.35% | 15.16% | 20.54% | |
74 Outperform | ¥28.08B | 8.12 | ― | 3.77% | 12.39% | -4.57% | |
67 Neutral | ¥276.16B | 18.33 | ― | 2.72% | 2.94% | 63.59% | |
66 Neutral | ¥276.80B | 11.66 | 11.17% | 2.61% | 5.12% | 12.69% | |
65 Neutral | ¥221.11B | 18.16 | ― | 2.23% | 3.35% | 7.82% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | ¥453.21B | 23.87 | 4.18% | 2.57% | 3.85% | -43.62% |